EMD-16522
Structure of ADDoCoV-ADAH11
EMD-16522
Single-particle4.06 Å
Deposition: 24/01/2023Map released: 06/12/2023
Last modified: 27/12/2023
Sample Organism:
Human adenovirus B3,
Lama glama
Sample: ADDoCoV-ADAH11
Deposition Authors: Yadav KNS, Buzas D
,
Berger-Schaffitzel C,
Berger I
Sample: ADDoCoV-ADAH11
Deposition Authors: Yadav KNS, Buzas D
,
Berger-Schaffitzel C,
Berger I
In vitro generated antibodies guide thermostable ADDomer nanoparticle design for nasal vaccination and passive immunization against SARS-CoV-2.
Buzas D ,
Bunzel AH,
Staufer O,
Milodowski EJ,
Edmunds GL ,
Bufton JC,
Vidana Mateo BV,
Yadav SKN,
Gupta K ,
Fletcher C,
Williamson MK,
Harrison A,
Borucu U,
Capin J,
Francis O ,
Balchin G,
Hall S,
Vega MV,
Durbesson F,
Lingappa S,
Vincentelli R,
Roe J,
Wooldridge L ,
Burt R,
Anderson RJL ,
Mulholland AJ ,
Hare J,
Bailey M ,
Davidson AD,
Finn A,
Morgan D ,
Mann J,
Spatz J ,
Garzoni F,
Schaffitzel C,
Berger I
(2023) Antib Ther , 6 , 277 - 297
,
Bunzel AH,
Staufer O,
Milodowski EJ,
Edmunds GL ,
Bufton JC,
Vidana Mateo BV,
Yadav SKN,
Gupta K ,
Fletcher C,
Williamson MK,
Harrison A,
Borucu U,
Capin J,
Francis O ,
Balchin G,
Hall S,
Vega MV,
Durbesson F,
Lingappa S,
Vincentelli R,
Roe J,
Wooldridge L ,
Burt R,
Anderson RJL ,
Mulholland AJ ,
Hare J,
Bailey M ,
Davidson AD,
Finn A,
Morgan D ,
Mann J,
Spatz J ,
Garzoni F,
Schaffitzel C,
Berger I
(2023) Antib Ther , 6 , 277 - 297
Grant Support:
- Wellcome Trust: 210701/Z/18/Z (United Kingdom)
- European Commission: 899670 (European Union)
- Wellcome Trust: 106115/Z/14/Z (United Kingdom)